Background After almost 2 years of fighting against SARS-CoV-2 pandemic, the number of
patients enduring persistent symptoms long after acute infection is a matter of concern. This …

The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …

Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …

The global spread of SARS-CoV-2 points to unrivaled mutational variation of the virus,
contributing to a variety of post-COVID sequelae in immunocompromised subjects and high …

To describe the rheumatic and musculoskeletal symptoms at hospitalization as well as their
persistence/severity after discharge with coronavirus disease 2019 (COVID-19) and to …

Immune thrombocytopenia (ITP) is a common hematological manifestation of systemic lupus
erythematosus (SLE). The heterogeneity of its clinical characteristics and therapeutic …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the coronavirus disease 19 (COVID-19) pandemic, which is deeply affecting the whole …

As the number of reports of post-acute COVID-19 musculoskeletal manifestations is rapidly
rising, it is important to summarize the current available literature in order to shed light on …

Objective Autoantibodies and autoimmune diseases after SARS-CoV-2 infection are widely
reported. Given evolving variants, milder infections, and increasing population vaccination …

The global health crisis caused by the COVID-19 pandemic overwhelmed the capacity of
healthcare systems to cope with the rapidly spreading infection and its associated …